Start Up the Science Start Up the Science

Welcome to "Start Up the Science," by INAM. Hosted by Taha Adnan, Marketing and Scouting Lead at INAM, this podcast explores the intersection of science, innovation, and entrepreneurship.
In today's episode, we're joined by David Giltner, the founder of TurningScience, a company that helps scientists and engineers transition from academia to industry. David shares his insights on the importance of understanding the business context, building a professional network, and developing a clear value proposition for your skills and expertise. We also explore some common misconceptions that scientists and engineers have about the industry and how to overcome them.
Whether you're a graduate student, postdoc, or early-career scientist, this episode is full of helpful tips and actionable advice for anyone looking to make the leap from academia to industry.
So sit back, relax, and join us as we dive into the exciting world of science entrepreneurship with David Giltner on "Start Up the Science."

On this episode of Start Up The Science, Ferdinand Rudolph Bartels, General Manager at SPECS Surface Analysis and Chairman of the INAM Board! Ferdinand has turned around multiple high tech ventures after coming on as a general manager and will discuss the ins and outs of the process with us. This episode was hosted by INAM's Managing Director, Oliver Hasse.
 
WATCH THE PODCAST ON YOUTUBE: https://youtu.be/otUss67ZVWY

On this episode of Start Up The Science, we talk to Jasper Van Hoorik, CEO and founder of BIO INX! BIO INX is developing the materials required to make bioprinting a reality! The long term goal of bioprinting is to fully 3D print organs and replace transplants. Through the use of their innovative materials, BIO INX helps keep the cells alive during and after printing. You can learn more about BIO INX here: www.bioinx.com
 
WATCH THE VIDEO VERSION OF THIS PODCAST ON YOUTUBE: https://youtu.be/He8H-6oX428

Mimotype is a developer and vendor of bio-inspired performance materials.
Our core skills: Initiating and steering end-to-end innovation cycles in the domain of bio-inspired materials research. The bioeconomy is about realigning production methods and supply chains with the vision of an ecologically seamless world economy. A deepened understanding of biology at the nanoscale will allow first-movers to become the technology leaders of the 21st century.
We have a prime candidate for a materials blockbuster in our material pipeline. Our focus is on a peptide – i.e. a mini-protein – that acts as the luminescent agent for the light-emission of marine life, a phenomenon known as "bioluminescence". We extract the genetic blueprint of said target molecule and then have genetically programmed bacteria produce the substance for us. The material obtained in this way is to be used for OLED displays and adjacent applications. In this industrial sector, there is a lack of high-performance emitter materials for the blue colour spectrum. If our stratagem works out, we will become the market leader in supplying a critical component for the display industry.
Moreover, in the long term, our approach can bring about a profound reshaping of the OLED technology mix. This will result in our materials IP becoming increasingly embedded in the value network of the target market.
Thanks to enormous advances in gene sequencing, exponentially increasing computing power and new gene-editing tools, humans have become core developers in the source code of life. As an investment thesis, Mimotype is a bet on an unconventional German biotech that reverse-engineers high-performance materials from nature's open source code.
Find out more about Mimotype Technologies by visiting Mimotype LinkedIn


For questions or comments, please email us at info@inam.berlin. Also, if you or someone you know would like to be a guest on our show, we welcome any and all suggestions!

Rhona Togher & Eimear O’Carroll are the co-founders of Lios. Together, they are creating elegant and practical solutions to enable a quieter world. Listen to their fascinating story on this episode of Start Up the Science!

Mark Jones is the CEO and Co-Founder of MQS - Molecular Quantum Solutions. MQS want to deliver modern and future computational tools to accelerate research & development efforts by the pharma, biotech and chemical industry.